Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

TEST OF HIV-SPECIFIC T LYMPHOCYTE FUNCTION THAT DETECTS EXPOSURE TO HIV ANTIGENS AND POSSIBLY EARLY HIV INFECTION

  • Read more about TEST OF HIV-SPECIFIC T LYMPHOCYTE FUNCTION THAT DETECTS EXPOSURE TO HIV ANTIGENS AND POSSIBLY EARLY HIV INFECTION
US Application 08/229,108
Filed on 1994-04-18

PROCESS FOR DETECTING ALZHEIMER DISEASE USING CULTURED CELLS

  • Read more about PROCESS FOR DETECTING ALZHEIMER DISEASE USING CULTURED CELLS
US Application 08/228,825
Filed on 1994-04-18

Administration of Cyclic AMP Analogues, Individually and in Pairs, to Inhibit Neoplastic Cell Growth

  • Read more about Administration of Cyclic AMP Analogues, Individually and in Pairs, to Inhibit Neoplastic Cell Growth
US Patent 5,843,916
Filed on 1994-04-08

DEVICE FOR MEASURING INCIDENT LIGHT IN A BODY CAVITY

  • Read more about DEVICE FOR MEASURING INCIDENT LIGHT IN A BODY CAVITY
US Patent 5,575,751
Filed on 1994-08-22

METHOD FOR ESTIMATING mRNA CONTENT BY FILTER HYBRIDIZATION TO A POLYTHYMIDYLATE PROBE

  • Read more about METHOD FOR ESTIMATING mRNA CONTENT BY FILTER HYBRIDIZATION TO A POLYTHYMIDYLATE PROBE
US Application 08/183,911
Filed on 1994-02-21

SENSITIVE METHOD FOR LOCALIZING CHROMOSOMAL BREAKPOINTS

  • Read more about SENSITIVE METHOD FOR LOCALIZING CHROMOSOMAL BREAKPOINTS
US Patent 5,582,973
Filed on 1993-12-02

METHOD OF MOBILIZING PLURIPOTENTIAL HEMATOPOIETIC STEM CELLS WITH IL-7

  • Read more about METHOD OF MOBILIZING PLURIPOTENTIAL HEMATOPOIETIC STEM CELLS WITH IL-7
US Patent 5,637,323
Filed on 1994-11-16

BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER

  • Read more about BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER
US Patent 5,696,154
Filed on 1994-06-29

HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE

  • Read more about HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE
US Application 08/224,973
Filed on 1994-04-08

PROCEDURE TO BLOCK THE REPLICATION OF REVERSE TRANSCRIPTASE DEPEN- DENT VIRUSES BY THE USE OF INHIBITORS OF DEOXYNUCLEOTIDES SYNTHESIS

  • Read more about PROCEDURE TO BLOCK THE REPLICATION OF REVERSE TRANSCRIPTASE DEPEN- DENT VIRUSES BY THE USE OF INHIBITORS OF DEOXYNUCLEOTIDES SYNTHESIS
US Patent 6,046,175
Filed on 1994-05-17

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1587
  • Page 1588
  • Page 1589
  • Page 1590
  • Page 1591
  • Page 1592
  • Page 1593
  • Page 1594
  • Page 1595
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health